Evidence map›Paper›PMID 36907895›Full record

ArticleJournal of animal science and biotechnology2023

Supplemental Clostridium butyricum modulates lipid metabolism by reshaping the gut microbiota composition and bile acid profile in IUGR suckling piglets.

Xin Zhang, Yang Yun, Zheng Lai, Shuli Ji, Ge Yu, Zechen Xie, Hao Zhang, Xiang Zhong, Tian Wang, Lili Zhang

Open access · goldFull text read
In one paragraph

Article in Journal of animal science and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Opportunistic Features of Non-Pathogens (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Probiotic Roles ofAnimals : an open access journal from MDPI · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xin ZhangCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Yang YunCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Zheng LaiCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Shuli JiCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Ge YuCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Zechen XieCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Hao ZhangCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Xiang ZhongCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Tian WangCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China.
Lili ZhangCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, Jiangsu, China. zhanglili@njau.edu.cn.ORCID http://orcid.org/0000-0002-4773-5157
Nanjing Agricultural University · CN

Funding

National Natural Science Foundation of China No. 31802101
6 · The paper itself

Abstract

backgroundIntrauterine growth restriction (IUGR) can cause lipid disorders in infants and have long-term adverse effects on their growth and development. Clostridium butyricum (C. butyricum), a kind of emerging probiotics, has been reported to effectively attenuate lipid metabolism dysfunctions. Therefore, the objective of this study was to investigate the effects of C. butyricum supplementation on hepatic lipid disorders in IUGR suckling piglets.

methodsSixteen IUGR and eight normal birth weight (NBW) neonatal male piglets were used in this study. From d 3 to d 24, in addition to drinking milk, the eight NBW piglets (NBW-CON group, n = 8) and eight IUGR piglets (IUGR-CON group, n = 8) were given 10 mL sterile saline once a day, while the remaining IUGR piglets (IUGR-CB group, n = 8) were orally administered C. butyricum at a dose of 2 × 10

resultsThe IUGR-CON piglets exhibited restricted growth, impaired hepatic morphology, disordered lipid metabolism, increased abundance of opportunistic pathogens and altered ileum and liver bile acid (BA) profiles. However, C. butyricum supplementation reshaped the gut microbiota of the IUGR-CB piglets, characterized by a decreased abundance of opportunistic pathogens in the ileum, including Streptococcus and Enterococcus. The decrease in these bile salt hydrolase (BSH)-producing microbes increased the content of conjugated BAs, which could be transported to the liver and function as signaling molecules to activate liver X receptor α (LXRα) and farnesoid X receptor (FXR). This activation effectively accelerated the synthesis and oxidation of fatty acids and down-regulated the total cholesterol level by decreasing the synthesis and promoting the efflux of cholesterol. As a result, the growth performance and morphological structure of the liver improved in the IUGR piglets.

conclusionThese results indicate that C. butyricum supplementation in IUGR suckling piglets could decrease the abundance of BSH-producing microbes (Streptococcus and Enterococcus). This decrease altered the ileum and liver BA profiles and consequently activated the expression of hepatic LXRα and FXR. The activation of these two signaling molecules could effectively normalize the lipid metabolism and improve the growth performance of IUGR suckling piglets.

Indexed as

Bile acidClostridium butyricumGut microbiotaIntrauterine growth restrictionLipid metabolismSuckling piglet

Identifiers

PMID36907895
PMCPMC10009951
OpenAlexW4323975107

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read37
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.